Wu Min, Yang Qin, Yim Anthony P C, Underwood Malcolm J, He Guo-Wei
Department of Surgery, The Chinese University of Hong Kong, Hong Kong; Guangdong Provincial People's Hospital, Guangzhou, China.
J Thorac Cardiovasc Surg. 2009 Feb;137(2):492-8. doi: 10.1016/j.jtcvs.2008.08.047. Epub 2008 Dec 19.
Pulmonary endothelial function is critical in posttransplant lung performance. Hyperkalemic organ preservation solutions alter vascular endothelial function through the non-nitric oxide and non-prostacyclin pathway, but the most frequently used lung preservation solutions, Perfadex (Vitrolife Sweden, Kungsbacka, Sweden) (K(+) 6 mmol/L) and Celsior (IMTIX SangStat Company, Lyon, France) (K(+) 15 mmol/L), have not been evaluated on pulmonary endothelial protection. We compared the non-nitric oxide and non-prostacyclin-mediated endothelial function in porcine pulmonary microarteries of lung preserved by Perfadex or Celsior solution at 4 degrees C for 4 hours.
The non-nitric oxide and non-prostacyclin-mediated endothelial function was determined by measuring the membrane potential in a single pulmonary smooth muscle cell (group II, n = 6) and bradykinin-induced relaxation (group I, n = 8) in pulmonary microarteries preserved in Krebs (a, control), Perfadex (b), or Celsior (c), with inhibitors of nitric oxide and prostacyclin.
Membrane potential hyperpolarization decreased in IIc (4.5 +/- 0.2 mV, P < .05) but was preserved (P > .05) in IIa (6.6 +/- 0.1 mV) and IIb (6.3 +/- 0.3 mV). Resting membrane potential was depolarized in IIc (-42.8 +/- 1.3 mV) compared with IIa (-58.7 +/- 0.6 mV) and IIb (-56.7 +/- 0.9 mV) (P < .05). Hyperpolarization-associated relaxation (37.3% +/- 7.2% vs 59.7% +/- 7.7%) and sensitivity (EC(50)) (-7.29 +/- 0.13 vs -7.75 +/- 0.06 log M) to bradykinin significantly (P < .05) decreased in Ic but not in Ia and Ib.
This in vitro study simulating clinical conditions demonstrates that Perfadex preserves endothelium-dependent smooth muscle relaxation and hyperpolarization better than Celsior solution in regard to the electrophysiologic and mechanical properties observed at cellular and vascular levels. This study provides a new method at the level of basic science to evaluate the solutions for heart/lung preservation.
肺内皮功能对移植后肺的性能至关重要。高钾器官保存液通过非一氧化氮和非前列环素途径改变血管内皮功能,但最常用的肺保存液,瑞典Vitrolife公司的Perfadex(钾离子浓度6 mmol/L)和法国IMTIX SangStat公司的Celsior(钾离子浓度15 mmol/L),尚未在肺内皮保护方面进行评估。我们比较了在4℃下用Perfadex或Celsior溶液保存4小时的猪肺微血管中,非一氧化氮和非前列环素介导的内皮功能。
通过测量单个肺平滑肌细胞的膜电位(II组,n = 6)和缓激肽诱导的肺微血管舒张(I组,n = 8)来确定非一氧化氮和非前列环素介导的内皮功能,这些肺微血管保存在Krebs液(a,对照)、Perfadex(b)或Celsior(c)中,并使用一氧化氮和前列环素抑制剂。
IIc组的膜电位超极化降低(4.5±0.2 mV,P <.05),而IIa组(6.6±0.1 mV)和IIb组(6.3±0.3 mV)则保持不变(P>.05)。与IIa组(-58.7±0.6 mV)和IIb组(-56.7±0.9 mV)相比,IIc组的静息膜电位去极化(-42.8±1.3 mV)(P <.05)。Ic组中与超极化相关的舒张(37.3%±7.2%对59.7%±7.7%)和对缓激肽的敏感性(半数有效浓度)(-7.29±0.13对-7.75±0.06 log M)显著降低(P <.05),而Ia组和Ib组则没有。
这项模拟临床情况的体外研究表明,就细胞和血管水平观察到的电生理和力学特性而言,Perfadex在保存内皮依赖性平滑肌舒张和超极化方面比Celsior溶液更好。本研究在基础科学层面提供了一种评估心肺保存液的新方法。